Mucous Membrane Pemphigoid

Dr. Heddie Sedano

PIC Homepage | Member Home
Page [ 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | Treatment | References ]

RECENT REFERENCES TO MUCOUS MEMBRANE PEMPHIGOID

  1. Allbritton JI; Nousari HC; Anhalt GJ. Anti-epiligrin (laminin 5) cicatricial pemphigoid. Brit J Derm 1997; 137:992-6.
  2. Balding SD; Prost C; Diaz LA; Bernard P; Bedane C; Aberdam D; Giudice GJ. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Derm 1996; 106:141-6.
  3. Bohm I; Bauer R. Treatment of bullous pemphigoid with low-dose methotrexate. Hautarzt 1997; 48:910-4.
  4. Carrozzo M; Broccoletti R; Carbone M; Garzino-Demo P; Gandolfo S. Pemphigoid of the mucous membranes. The clinical, histopathological and immunological aspects and current therapeutic concepts. Minerva Stomatol 1996; 45:455-63.
  5. Chan LS; Majmudar AA; Tran HH; Meier F; Schaumburg-Lever G; Chen M; Anhalt G; Woodley DT; Marinkovich MP. Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. J Invest Derm1997; 108:848-53.
  6. Eversole LR.Immunopathology of oral mucosal ulcerative, desquamative, and bullous diseases. Selective review of the literature Oral Surg Oral Med Oral Pathol Oral Radiol Endodont 1994;77:555-71.
  7. Helander SD; Rogers RS 3rd. The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes. J Amer Acad Dermatol 1994; 30:65-75.
  8. Mutasim DF, Pelc NJ, Anhalt GJ. Cicatricial pemphigoid. Der Clin 1993;11:499-509.
  9. Lozada-Nur F; Miranda C; Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases Oral Surg Oral Med Oral Pathol Oral Radiol Endodont 1994; 77:598-604.
  10. Mobini N; Nagarwalla N; Ahmed AR. Oral pemphigoid. Subset of cicatricial pemphigoid? Oral Surg Oral Med Oral Pathol Oral Radiol Endodont 1998; 85:37-43.
  11. Paul MA; Jorizzo JL; Fleischer AB Jr; White WL. Low-dose methotrexate treatment in elderly patients with bullous pemphigoid. J Amer Acad Dermatol 1994; 31:620-5.
  12. Scully C; Porter SR. The clinical spectrum of desquamative gingivitis. Seminars in Cutaneous Med Surg 1997;16:308-13.
  13. Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles. Clin Exper Derm 1996; 21:23-7.
  14. Weinberg MA; Insler MS; Campen RB. Mucocutaneous features of autoimmune blistering diseases Oral Surg Oral Med Oral Pathol Oral Radiol Endodont 1997; 84:517-34.
  15. Yancey KB; Kirtschig G; Yee C; Lazarova Z. Studies of patients with anti-epiligrin cicatricial pemphigoid. J Derm 1995; 22:829-35.
  16. Zillikens D; Kawahara Y; Ishiko A; Shimizu H; Mayer J; Rank CV; Liu Z; Giudice GJ; Tran HH; Marinkovich MP; et al. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone [corrected and republished article originally printed in J Invest Dermatol 1996 Mar;106(3):465-70 J Invest Dermatol1996;106:1333-8.
Top